Cardiovascular Disease, Growth Hormone, and the Complexities of Heart Health

TLDR The podcast delves into the intricacies of cardiovascular disease, highlighting the causes of heart attacks, advancements in cardiology procedures, the impact of stents, and the interplay between growth hormone, insulin, and metabolism. It also discusses the challenges in preventive medicine decision-making and the development of innovative tools like the Keyto system for individuals on a ketogenic diet.

Timestamped Summary

00:00 The podcast episode features a discussion between Peter Attia and Dr. Ethan Weiss on the interconnected topics of cardiovascular disease and growth hormone.
08:40 A personal story about attending a hockey game and acquiring a signed Gretzky jersey at a charity auction is shared.
16:47 Attending medical school at Hopkins was initially intimidating due to the high achievers and intense pressure, but ultimately became an inspiring and rewarding experience.
24:25 The primary cause of most heart attacks is a ruptured atherosclerotic plaque, not just a narrowing of the artery, with clot formation being the instigator due to the exposure of tissue factor by macrophages.
32:16 Myocardial infarction is traditionally defined by chest pain, changes in the electrocardiogram, and the presence of biomarkers, with the EKG being a fundamental tool in determining treatment.
40:19 Symptoms of coronary disease develop slowly over time, with most people becoming symptomatic when there is about a 70% blockage in the arteries, but there is no clear correlation between the percentage of blockage and the risk of a fatal event.
48:29 Advancements in cardiology have led to more efficient and standardized procedures for opening blocked arteries, such as primary angioplasty and the use of stents to prevent artery recoil.
56:21 Drug-eluting stents were developed to prevent instant restenosis by inhibiting cell proliferation on the stent, but they led to a new issue of late stent thrombosis due to inhibiting endothelial cell growth.
01:04:14 The body's response to a metal stent can either lead to the formation of a protective endothelium or trigger an inflammatory cascade, impacting the risk of stent thrombosis.
01:12:19 Patients with ST elevation MI (STEMI) are immediately sent for intervention, while those with non-STEMI are managed either medically or through interventional cardiology, depending on their stability and symptoms.
01:20:04 Stents may not provide significant benefits in reducing heart attack risk or symptoms, highlighting the importance of medical therapy in managing cardiovascular disease.
01:28:12 Managing stable angina with medications is crucial before considering stent placement, as the decision to proceed with stenting should be based on optimizing patient outcomes and minimizing potential risks associated with the procedure.
01:36:10 Prevention in medicine often requires a long-term approach that may not fit neatly into traditional clinical trial structures, leading to challenges in decision-making for preventive measures.
01:44:01 Interpreting calcium scores in the context of age is crucial for understanding cardiovascular risk.
01:52:02 Plaque growth in arteries can be detected before significant narrowing occurs, providing valuable information for cardiovascular risk assessment.
01:59:39 Heartflow's CTFFR software may not be a significant game changer in cardiovascular practice due to its limited added value in guiding medical therapy.
02:07:48 Knocking out Jack2 in the liver leads to fat accumulation in the liver due to disrupted growth hormone signaling and increased uptake facilitated by CD36.
02:15:36 Blocking the growth hormone signaling pathway in adipocytes led to increased insulin sensitivity and profound hypoglycemia in mice, revealing the complex interplay between growth hormone and insulin in regulating metabolism.
02:23:42 The complex relationship between IGF, GH signaling, and longevity reveals conflicting information on the impact of GH on lifespan and disease risk.
02:31:51 Insulin plays a role in cardiovascular disease, and while growth hormone may not promote longevity, it could be beneficial for improving physical appearance and muscle mass.
02:39:53 Science communication is crucial, and there is a need to make scientific topics more interesting and accessible to a wider audience.
02:47:26 A sensor-based system called Keyto has been developed to provide information and guidance for individuals following a ketogenic diet, aiming to make the process more accessible and successful.
Categories: Health & Fitness

Cardiovascular Disease, Growth Hormone, and the Complexities of Heart Health

Ethan Weiss, M.D.: A masterclass in cardiovascular disease and growth hormone - two topics that are surprising interrelated
by The Peter Attia Drive

Browse more Health & Fitness